📣 VC round data is live. Check it out!
- Public Comps
- NeuroOne Medical
NeuroOne Medical Valuation Multiples
Discover revenue and EBITDA valuation multiples for NeuroOne Medical and similar public comparables like Vivos, Implanet, Trajan Group Holdings, Acarix and more.
NeuroOne Medical Overview
About NeuroOne Medical
NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.
Founded
2009
HQ

Employees
18
Website
Financials (LTM)
EV
$29M
Valuation Multiples
Start free trialNeuroOne Medical Financials
NeuroOne Medical reported last 12-month revenue of $10M.
In the same LTM period, NeuroOne Medical generated $6M in gross profit and had net loss of ($6M).
Revenue (LTM)
NeuroOne Medical P&L
In the most recent fiscal year, NeuroOne Medical reported revenue of $9M and EBITDA of ($3M).
NeuroOne Medical is unprofitable as of last fiscal year, with gross margin of 57%, EBITDA margin of (33%), and net margin of (40%).
Financial data powered by Morningstar, Inc.
NeuroOne Medical Stock Performance
NeuroOne Medical has current market cap of $32M, and enterprise value of $29M.
Market Cap Evolution
NeuroOne Medical's stock price is $3.69.
NeuroOne Medical share price decreased by 21.5% in the last 30 days, and increased by 503.8% in the last year.
NeuroOne Medical has an EPS (earnings per share) of $-0.42.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $29M | $32M | 0.0% | -21.5% | -8.0% | 503.8% | $-0.42 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialNeuroOne Medical Valuation Multiples
NeuroOne Medical trades at 2.9x EV/Revenue multiple, and (9.7x) EV/EBITDA.
EV / Revenue (LTM)
NeuroOne Medical Financial Valuation Multiples
As of May 26, 2026, NeuroOne Medical has market cap of $32M and EV of $29M.
NeuroOne Medical has a P/E ratio of (5.4x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified NeuroOne Medical Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


NeuroOne Medical Margins & Growth Rates
NeuroOne Medical grew revenue by 19% and net profit by 96% in the last fiscal year.
In the most recent fiscal year, NeuroOne Medical reported gross margin of 57%, EBITDA margin of (33%), and net margin of (40%).
NeuroOne Medical Margins
NeuroOne Medical Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
NeuroOne Medical Operational KPIs
NeuroOne Medical's revenue per employee in the last FY averaged $0.5M, while opex per employee averaged $0.5M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
NeuroOne Medical Competitors
NeuroOne Medical competitors include Vivos, Implanet, Trajan Group Holdings, Acarix, Bioretec, Carclo, Nortech Systems, CytoSorbents, Spirit Scientific Co and aap Implantate.
Most NeuroOne Medical public comparables operate across Medical Devices, HealthTech and DeepTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| — | — | — | — | |||
| 2.4x | — | (8.1x) | — | |||
| 0.5x | 0.5x | 6.4x | 5.8x | |||
| 36.0x | 22.6x | (6.2x) | (7.3x) | |||
| 7.1x | 5.9x | (3.0x) | (3.2x) | |||
| 0.4x | 0.4x | 3.0x | 2.7x | |||
| 0.4x | — | 22.3x | — | |||
| 1.4x | 1.4x | (12.3x) | — | |||
This data is available for Pro users. Sign up to see all NeuroOne Medical competitors and their valuation data. Start Free Trial | ||||||
NeuroOne Medical Funding History
Before going public, NeuroOne Medical raised $3M in total equity funding, across 5 rounds.
NeuroOne Medical Funding Rounds
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout NeuroOne Medical
| When was NeuroOne Medical founded? | NeuroOne Medical was founded in 2009. |
| Where is NeuroOne Medical headquartered? | NeuroOne Medical is headquartered in United States. |
| How many employees does NeuroOne Medical have? | As of today, NeuroOne Medical has over 18 employees. |
| Who is the CEO of NeuroOne Medical? | NeuroOne Medical's CEO is David A. Rosa. |
| Is NeuroOne Medical publicly listed? | Yes, NeuroOne Medical is a public company listed on Nasdaq. |
| What is the stock symbol of NeuroOne Medical? | NeuroOne Medical trades under NMTC ticker. |
| When did NeuroOne Medical go public? | NeuroOne Medical went public in 2012. |
| Who are competitors of NeuroOne Medical? | NeuroOne Medical main competitors include Vivos, Implanet, Trajan Group Holdings, Acarix, Bioretec, Carclo, Nortech Systems, CytoSorbents, Spirit Scientific Co, aap Implantate. |
| What is the current market cap of NeuroOne Medical? | NeuroOne Medical's current market cap is $32M. |
| What is the current revenue of NeuroOne Medical? | NeuroOne Medical's last 12 months revenue is $10M. |
| What is the current revenue growth of NeuroOne Medical? | NeuroOne Medical revenue growth (NTM/LTM) is 30%. |
| What is the current EV/Revenue multiple of NeuroOne Medical? | Current revenue multiple of NeuroOne Medical is 2.9x. |
| Is NeuroOne Medical profitable? | No, NeuroOne Medical is not profitable. |
| What is the current net income of NeuroOne Medical? | NeuroOne Medical's last 12 months net income is ($6M). |
| How many companies NeuroOne Medical has acquired to date? | NeuroOne Medical hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies NeuroOne Medical has invested to date? | NeuroOne Medical hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to NeuroOne Medical
Lists including NeuroOne Medical
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.